Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
1,317
Total Claims
$6.8M
Drug Cost
202
Beneficiaries
$33K
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 3,372 Medical Oncology providers
+166%
Opioid rate vs peers
15.6% vs 5.9% avg
+174%
Cost per patient vs peers
$33K vs $12K avg
Opioid Prescribing
15.6%
Opioid Rate
205
Opioid Claims
$5,182
Opioid Cost
24.4%
Long-Acting Rate
Brand vs Generic
Brand: 0 claims · $0
Generic: 794 claims · $269K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Lenalidomide | 177 | $3.4M |
| Pomalidomide | 40 | $988K |
| Ibrutinib | 41 | $696K |
| Acalabrutinib Maleate | 22 | $330K |
| Lenalidomide | 12 | $239K |
| Ruxolitinib Phosphate | 13 | $235K |
| Venetoclax | 16 | $205K |
| Apixaban | 70 | $66K |
| Rivaroxaban | 53 | $48K |
| Dabigatran Etexilate Mesylate | 28 | $9,827 |
| Hydroxyurea | 71 | $2,413 |
| Oxycodone Hcl/Acetaminophen | 73 | $2,031 |
| Dexamethasone | 131 | $1,584 |
| Morphine Sulfate | 44 | $1,426 |
| Acyclovir | 38 | $853 |
Prescribing Profile
Patient Profile
70
Avg Age
49%
Female
2.42
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data